Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and Neovascularization in infarcted myocardium
Angiogenesis: escape from hypoxia
Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease - A meta-analysis
Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer
Angiopoietin: A TIE(d) balance in tumor angiogenesis
Angiopoietin-2 stimulates breast cancer metastasis through the beta-501 integrin-mediated pathway
Angiopoietins in malignancy
Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers
Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer
Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas
Angiopoietin-1 and-2 expression in recurrent squamous cell carcinoma of the oral cavity
Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alpha(v)beta(1) integrin and focal adhesion kinase signaling pathway
Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy
Angiogenesis and lymphangiogenesis: highlights of the past year
Angiotensin II-Dependent Transcriptional Activation of Human Steroidogenic Acute Regulatory Protein Gene by a 25-kDa cAMP-Responsive Element Modulator Protein Isoform and Yin Yang 1
Angiogenic morphogenesis driven by dynamic and heterogeneous collective endothelial cell movement
Angiotensin AT(2) Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke
Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation
Angiotensin receptor blockers, and cerebral protection in stroke
Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: Relevance to multiple sclerosis
Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy
Angiotensin II-Induced osteopontin expression in vascular smooth muscle cells involves G(q/11), Ras, ERK, Src and Ets-1
Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium
Angiogenesis of gastrointestinal tumours and their metastases - a target for intervention?
Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy
Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin
Angiotensin II Type 1 Receptor Signaling Regulates Feeding Behavior through Anorexigenic Corticotropin-releasing Hormone in Hypothalamus
Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA
Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide
Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats
Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells - A novel cross-talk in the pathogenesis of atherosclerosis
Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT(1) receptor in guinea pig atrial myocytes
Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition
Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium
Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction
Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II
Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-Deficient mice
Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells
Angiogenic potential of human macrophages on electrospun bioresorbable vascular grafts
Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis
Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 Association
Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies
Angiographic Characteristics of Intermediate Stenosis of the Left Anterior Descending Artery for Determination of Lesion Significance as Identified by Fractional Flow Reserve
Angiogenesis and anti-angiogenic therapy in prostate cancer
Angiopoietin-like protein 2 renders colorectal cancer cells resistant to chemotherapy by activating spleen tyrosine kinase-phosphoinositide 3-kinase-dependent anti-apoptotic signaling
Angiogenesis as a Therapeutic Target in Malignant Gliomas
Angiotensin II receptor on BALF macrophages from Japanese patients with active sarcoidosis
Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1 alpha in human glioblastoma
Angiogenesis of Lung Cancer Utilizes Existing Blood Vessels Rather than Developing New Vessels Using Signals from Carcinogenesis
Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors
Angiogenesis and the role of epigenetics in metastasis
Angiogenesis research: Guidelines for translation to clinical application
Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)
Angiogenesis Inhibition in Non-GIST Soft Tissue Sarcomas
Angiogenesis: All a radiation oncologist should know
Angiogenesis inhibitor therapies: focus on hypertension and kidney toxicity
Angiogenesis targeting in lung cancers
Angiogenesis targeting in renal carcinomas
Angiogenesis as a therapeutic target in urothelial carcinoma
Angiotensinogen messenger RNA stabilization by angiotensin II
Angiogenesis as a therapeutic target in cancer
Angiopoietin-1 Requires IQ Domain GTPase-Activating Protein 1 to Activate Rac1 and Promote Endothelial Barrier Defense
Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells
Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes
Angiography Is the Gold Standard and Objective Evidence of Myocardial Ischemia Is Mandatory If Lesion Severity Is Questionable - Indication of PCI for Angiographically Significant Coronary Artery Stenosis Without Objective Evidence of Myocardial Ischemia (Pro)
Angiogenesis: A prognostic determinant in pancreatic cancer?
Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice
Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
Angiotensinogen gene and hypertension in Chinese
Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience
Angiogenesis and the growth potential of craniopharyngiomas
Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer
Angiogenesis and renal cell carcinoma
Angiotensin Peptides and Lung Cancer
Angiogenic Sprouting Requires the Fine Tuning of Endothelial Cell Cohesion by the Raf-1/Rok-alpha Complex
Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT(2)) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1
Angiogenesis and capillary maturation phenotypes associated with the Edpm3 locus on rat chromosome 3
Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1)
Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox
Angiotensin Converting Enzyme 2 Contributes to Sex Differences in the Development of Obesity Hypertension in C57BL/6 Mice